Oncolytic Virotherapyhttps://www.dovepress.com/feed/journal/141New articles released by Dove Press for Oncolytic Virotherapyen-us2026, Dove Pressangela@dovepress.com (Angela Jones)Dove Press Oncolytic VirotherapyOncolytic Virotherapyhttps://www.dovepress.com/feed/journal/141https://www.dovepress.com/assets/img/addon/rss-banner.jpg140140The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatmenthttps://www.dovepress.com/the-current-state-of-oncolytic-herpes-simplex-virus-for-glioblastoma-t-peer-reviewed-fulltext-article-OVOncolytic VirotherapyWed, 24 Feb 2021 08:51:00 +1300https://doi.org/10.2147/OV.S268426Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinibhttps://www.dovepress.com/treatment-of-an-alveolar-rhabdomyosarcoma-allograft-with-recombinant-m-peer-reviewed-fulltext-article-OVOncolytic VirotherapyTue, 26 May 2020 10:48:00 +1200https://doi.org/10.2147/OV.S252727Virus–Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Developmenthttps://www.dovepress.com/virusndashreceptor-interactions-and-virus-neutralization-insights-for--peer-reviewed-fulltext-article-OVOncolytic VirotherapyFri, 06 Mar 2020 09:46:00 +1300https://doi.org/10.2147/OV.S186337Impact of Induced Syncytia Formation on the Oncolytic Potential of Myxoma Virushttps://www.dovepress.com/impact-of-induced-syncytia-formation-on-the-oncolytic-potential-of-myx-peer-reviewed-fulltext-article-OVOncolytic VirotherapyMon, 09 Dec 2019 11:57:00 +1300https://doi.org/10.2147/OV.S220420Virus–Receptor Interactions: Structural Insights For Oncolytic Virus Developmenthttps://www.dovepress.com/virus-receptor-interactions-structural-insights-for-oncolytic-virus-de-peer-reviewed-fulltext-article-OVOncolytic VirotherapyTue, 29 Oct 2019 15:08:00 +1300https://doi.org/10.2147/OV.S218494Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Gliomahttps://www.dovepress.com/preclinical-and-clinical-development-of-oncolytic-adenovirus-for-the-t-peer-reviewed-fulltext-article-OVOncolytic VirotherapyThu, 24 Oct 2019 09:25:00 +1300https://doi.org/10.2147/OV.S196403Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypeshttps://www.dovepress.com/directed-evolution-as-a-tool-for-the-selection-of-oncolytic-rna-viruse-peer-reviewed-fulltext-article-OVOncolytic VirotherapyFri, 12 Jul 2019 11:42:00 +1200https://doi.org/10.2147/OV.S176523A cautionary note on the selectivity of oncolytic poxviruseshttps://www.dovepress.com/a-cautionary-note-on-the-selectivity-of-oncolytic-poxviruses-peer-reviewed-fulltext-article-OVOncolytic VirotherapyMon, 11 Feb 2019 15:15:00 +1300https://doi.org/10.2147/OV.S189832Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma [Corrigendum]https://www.dovepress.com/corrigendum-oncolytic-virotherapy-including-rigvir-and-standard-t-peer-reviewed-fulltext-article-OVOncolytic VirotherapyFri, 04 Jan 2019 15:40:00 +1300https://doi.org/10.2147/OV.S196145Development and applications of oncolytic Maraba virus vaccineshttps://www.dovepress.com/development-and-applications-of-oncolytic-maraba-virus-vaccines-peer-reviewed-fulltext-article-OVOncolytic VirotherapyMon, 26 Nov 2018 10:51:00 +1300https://doi.org/10.2147/OV.S154494Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiformehttps://www.dovepress.com/oncolytic-myxoma-virus-synergizes-with-standard-of-care-for-treatment--peer-reviewed-fulltext-article-OVOncolytic VirotherapyMon, 19 Nov 2018 15:15:00 +1300https://doi.org/10.2147/OV.S179335Oral poliovirus vaccine-induced programmed cell death involves both intrinsic and extrinsic pathways in human colorectal cancer cellshttps://www.dovepress.com/oral-poliovirus-vaccine-induced-programmed-cell-death-involves-both-in-peer-reviewed-fulltext-article-OVOncolytic VirotherapyTue, 30 Oct 2018 12:20:00 +1300https://doi.org/10.2147/OV.S177260Three-dimensional tumor cell cultures employed in virotherapy researchhttps://www.dovepress.com/three-dimensional-tumor-cell-cultures-employed-in-virotherapy-research-peer-reviewed-fulltext-article-OVOncolytic VirotherapyWed, 05 Sep 2018 12:05:00 +1200https://doi.org/10.2147/OV.S165479Oncolytic virus and PD-1/PD-L1 blockade combination therapyhttps://www.dovepress.com/oncolytic-virus-and-pd-1pd-l1-blockade-combination-therapy-peer-reviewed-fulltext-article-OVOncolytic VirotherapyTue, 31 Jul 2018 15:25:00 +1200https://doi.org/10.2147/OV.S145532Current understanding of reovirus oncolysis mechanismshttps://www.dovepress.com/current-understanding-of-reovirus-oncolysis-mechanisms-peer-reviewed-fulltext-article-OVOncolytic VirotherapyThu, 14 Jun 2018 13:47:00 +1200https://doi.org/10.2147/OV.S143808Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancerhttps://www.dovepress.com/oncolytic-adenovirus-ad657-for-systemic-virotherapy-against-prostate-c-peer-reviewed-fulltext-article-OVOncolytic VirotherapyThu, 03 May 2018 11:17:00 +1200https://doi.org/10.2147/OV.S155946Proof-of-principle that a decoy virus protects oncolytic measles virus against neutralizing antibodieshttps://www.dovepress.com/proof-of-principle-that-a-decoy-virus-protects-oncolytic-measles-virus-peer-reviewed-fulltext-article-OVOncolytic VirotherapyMon, 30 Apr 2018 10:41:00 +1200https://doi.org/10.2147/OV.S150637The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruseshttps://www.dovepress.com/the-importance-of-imaging-strategies-for-pre-clinical-and-clinical-in--peer-reviewed-fulltext-article-OVOncolytic VirotherapyWed, 28 Mar 2018 12:50:00 +1300https://doi.org/10.2147/OV.S137159Oncolytic virotherapy in upper gastrointestinal tract cancershttps://www.dovepress.com/oncolytic-virotherapy-in-upper-gastrointestinal-tract-cancers-peer-reviewed-fulltext-article-OVOncolytic VirotherapyFri, 23 Mar 2018 16:05:00 +1300https://doi.org/10.2147/OV.S161397Potential of oncolytic viruses in the treatment of multiple myelomahttps://www.dovepress.com/potential-of-oncolytic-viruses-in-the-treatment-of-multiple-myeloma-peer-reviewed-fulltext-article-OVOncolytic VirotherapyFri, 23 Feb 2018 14:02:00 +1300https://doi.org/10.2147/OV.S136644Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effecthttps://www.dovepress.com/oncolytic-virus-delivery-from-nano-pharmacodynamics-to-enhanced-oncoly-peer-reviewed-fulltext-article-OVOncolytic VirotherapyWed, 08 Nov 2017 14:58:00 +1300https://doi.org/10.2147/OV.S145262Curative effect of HF10 on liver and peritoneal metastasis mediated by host antitumor immunityhttps://www.dovepress.com/curative-effect-of-hf10-on-liver-and-peritoneal-metastasis-mediated-by-peer-reviewed-fulltext-article-OVOncolytic VirotherapyMon, 13 Mar 2017 17:04:00 +1300https://doi.org/10.2147/OV.S127179Proinflammatory response induced by Newcastle disease virus in tumor and normal cellshttps://www.dovepress.com/proinflammatory-response-induced-by-newcastle-disease-virus-in-tumor-a-peer-reviewed-fulltext-article-OVOncolytic VirotherapyFri, 03 Mar 2017 15:28:00 +1300https://doi.org/10.2147/OV.S123292Editorial announcing PubMed indexing of Oncolytic Virotherapyhttps://www.dovepress.com/editorial-announcing-pubmed-indexing-of-oncolytic-virotherapy-peer-reviewed-fulltext-article-OVOncolytic VirotherapyWed, 15 Feb 2017 12:37:00 +1300https://doi.org/10.2147/OV.S128720Oncolytic virotherapy including Rigvir and standard therapies in malignant melanomahttps://www.dovepress.com/oncolytic-virotherapy-including-rigvir-and-standard-therapies-in-malig-peer-reviewed-fulltext-article-OVOncolytic VirotherapyThu, 09 Feb 2017 14:24:00 +1300https://doi.org/10.2147/OV.S100072Novel oncolytic viral therapies in patients with thoracic malignancieshttps://www.dovepress.com/novel-oncolytic-viral-therapies-in-patients-with-thoracic-malignancies-peer-reviewed-fulltext-article-OVOncolytic VirotherapyWed, 21 Dec 2016 10:44:00 +1300https://doi.org/10.2147/OV.S116012CXCL12 retargeting of an adenovirus vector to cancer cells using a bispecific adapterhttps://www.dovepress.com/cxcl12-retargeting-of-an-adenovirus-vector-to-cancer-cells-using-a-bis-peer-reviewed-fulltext-article-OVOncolytic VirotherapyFri, 11 Nov 2016 16:20:00 +1300https://doi.org/10.2147/OV.S112107Spotlight on talimogene laherparepvec for the treatment of melanoma lesions in the skin and lymph nodeshttps://www.dovepress.com/spotlight-on-talimogene-laherparepvec-for-the-treatment-of-melanoma-le-peer-reviewed-fulltext-article-OVOncolytic VirotherapyTue, 04 Oct 2016 14:36:00 +1300https://doi.org/10.2147/OV.S99532Oncolytic Seneca Valley Virus: past perspectives and future directionshttps://www.dovepress.com/oncolytic-seneca-valley-virus-past-perspectives-and-future-directions-peer-reviewed-fulltext-article-OVOncolytic VirotherapyTue, 06 Sep 2016 11:38:00 +1200https://doi.org/10.2147/OV.S96915Oncolytic virotherapy for pediatric malignancies: future prospectshttps://www.dovepress.com/oncolytic-virotherapy-for-pediatric-malignancies-future-prospects-peer-reviewed-fulltext-article-OVOncolytic VirotherapyThu, 11 Aug 2016 13:35:00 +1200https://doi.org/10.2147/OV.S96932